Clinical trial
Efficacy and Tolerance of Cellularised LG002 Versus Uncellularised LG002 in the…
NCT00366041 · Laboratoires Genévrier, Industry · Terminated
Key facts
| NCT number | NCT00366041 |
|---|---|
| Title | Efficacy and Tolerance of Cellularised LG002 Versus Uncellularised LG002 in the Treatment of Severe Burns Injuries |
| Official title | Multicentre Clinical Study to Compare the Efficacy and the Tolerance of Cellularised LG002 With the Efficacy and Tolerance of Uncellularised LG002 in the Treatment of Severe Burn Injury |
| Lead sponsor | Laboratoires Genévrier, Industry |
| Collaborators | Hôpital d'Instruction des Armées de Percy Institut National de la Santé Et de la Recherche Médicale, France |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Burns |
| Intervention type | Device, Drug |
| Interventions | Dermal substrate cellularised LG002 (10x10cm), Dermal substrate uncellularised LG002 (10x10 cm) |
| Enrollment | 20 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Aug 18, 2006 |
| Last update posted | Jan 21, 2010 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: